Drug-Coated Balloon Surface Roughness Modulates Intraprocedural Contact Mechanics and Delivery Efficiency: An In-Silico Study
Preprint
- 9 September 2025
- preprint
- Published by MDPI AG in Preprints.org
Abstract
The global prevalence of peripheral artery disease (PAD) continues to rise, driving the increasing clinical use of drug-coated balloons (DCBs). These devices traditionally deliver the antiproliferative drug Paclitaxel (PTX) or its derivatives to the lesion site and have demonstrated superior effectiveness over plain old balloon angioplasty in mitigating post-interventional restenosis. Despite improved clinical outcomes, concerns with inefficient intraprocedural PTX transfer to the arterial wall and resultant off-target/systemic effects remain. This study utilizes DCB-arterial wall structural contact modeling to identify how the microstructural features of urea-based coatings modulate drug transfer efficiency, with consideration of both traditional PTX and recently proposed multi-drug payloads that also deliver the smooth muscle cell relaxant Valsartan (VAL). We incorporated experimentally-obtained measures of coating surface microstructures of PTX-urea and PTX-VAL-urea coatings into finite element models that simulate key physical processes in DCB deployment, namely device-tissue mechanical contact and diffusion-mediated drug transport. Model predictions enable the interrelation of coating surface microstructure to intraprocedural tissue-arterial wall contact area, mechanical load distribution, and drug-specific transfer to the arterial wall. Our findings suggest that coating microstructure modulates the transfer efficiency of PTX but not VAL, which is understood as a consequence of the procedural duration and relative molecular weights/mobilities of these drugs. Taken together, our study underscores the complexity of coating design/dosing for multi-drug payloads and supports the use of computational modeling in the device design process.Keywords
All Related Versions
This publication has 34 references indexed in Scilit:
- Towards the Integration of an Anti-Contractile Compound Within Drug-Coated Balloon TherapyCardiovascular Engineering and Technology, 2025
- Investigating Balloon-Vessel Contact Pressure Patterns in Angioplasty: In Silico Insights for Drug-Coated BalloonsAnnals of Biomedical Engineering, 2023
- 5-Year Outcomes of Drug-Coated Balloons for Peripheral Artery In-Stent Restenosis, Long Lesions, and CTOsJACC: Cardiovascular Interventions, 2023
- Population Pharmacokinetic Analysis of Valsartan in Healthy Chinese SubjectsClinical Pharmacology in Drug Development, 2022
- Understudied factors in drug‐coated balloon design and evaluation: A biophysical perspectiveBioengineering & Translational Medicine, 2022
- Long‐term clinical outcome and mortality risks after paclitaxel‐coated balloon angioplasty in patients with peripheral artery disease: An observational clinical studyHealth Science Reports, 2021
- Balloon-based drug coating delivery to the artery wall is dictated by coating micro-morphology and angioplasty pressure gradientsBiomaterials, 2020
- Coating and Pharmacokinetic Evaluation of Air Spray Coated Drug Coated BalloonsCardiovascular Engineering and Technology, 2018
- Stent elution rate determines drug deposition and receptor-mediated effectsJournal of Controlled Release, 2012
- Mechanical properties, urea diffusion, and cell cultural response of poly(vinyl alcohol)–Chitosan bioartificial membranes via molecular modelling and experimental investigationComposites Part B: Engineering, 2012